Kedrion S.p.A.

Quick facts

Marketed products

• Kedbumin 25% · Critical Care / Hematology
  Kedbumin 25% is a human serum albumin solution that restores and maintains oncotic pressure and serves as a carrier protein for endogenous and exogenous substances in the bloodstream.

Phase 3 pipeline

• Coagadex(R) · Hematology
  Coagadex is a recombinant human vitamin K-dependent clotting factor X that replaces deficient or dysfunctional Factor X to restore blood coagulation.
• Kedrion IVIG 10% · Immunology
  Kedrion IVIG 10% is an intravenous immunoglobulin preparation that provides passive immunity by supplying pooled human antibodies to modulate immune responses and neutralize pathogens.

Phase 2 pipeline

• Human Plasminogen · Cardiovascular
  Activates plasminogen to break down blood clots

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kedrion S.p.A. portfolio CI brief
• Kedrion S.p.A. pipeline updates RSS